Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$543M |
| 2 |
ExxonMobil
XOM
|
+$75.8M |
| 3 |
Trip.com Group
TCOM
|
+$57M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$56.8M |
| 5 |
Alibaba
BABA
|
+$52.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toyota
TM
|
+$571M |
| 2 |
Chevron
CVX
|
+$76.5M |
| 3 |
SFG
STANCORP FINL GRP
SFG
|
+$39.1M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$36.4M |
| 5 |
Gilead Sciences
GILD
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.2% |
| 2 | Healthcare | 14.84% |
| 3 | Technology | 13.02% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Industrials | 6.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$460B
| $583M | 1.22% |
19,358,065
+369
| +0% | +$10.7K |
|
27
TSMC
TSM
$2.09T
| $571M | 1.19% |
27,517,403
+903,024
| +3% | +$19M |
|
28
Novartis
NVS
$301B
| $564M | 1.17% |
6,843,547
+86,569
| +1% | +$7.7M |
|
29
Procter & Gamble
PG
$335B
| $563M | 1.17% |
7,830,151
+68,765
| +0.9% | +$5.16M |
|
30
UBS Group
UBS
$175B
| $512M | 1.07% |
27,651,070
+1,106,189
| +4% | +$23.4M |
|
31
Qualcomm
QCOM
$160B
| $504M | 1.05% |
9,387,122
-58,761
| -0.6% | -$3.49M |
|
|
32
AB InBev
BUD
$166B
| $502M | 1.05% |
4,721,105
+4,674,824
| +10,101% | +$543M |
|
33
PepsiCo
PEP
$191B
| $497M | 1.04% |
5,271,048
+51,197
| +1% | +$4.87M |
|
|
FLGE
34
DELISTED
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
| $493M | 1.03% |
4,564,927
-67,439
| -1% | -$8.15M |
|
35
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $472M | 0.98% |
15,450,841
+1,039,469
| +7% | +$31.7M |
|
36
HDFC Bank
HDB
$124B
| $451M | 0.94% |
29,535,972
+658,692
| +2% | +$9.94M |
|
37
GSK
GSK
$104B
| $443M | 0.92% |
9,222,455
-4,242
| -0% | -$221K |
|
38
HSBC
HSBC
$367B
| $434M | 0.9% |
12,863,363
-604,670
| -4% | -$22.6M |
|
39
Coca-Cola
KO
$381B
| $413M | 0.86% |
10,293,030
+87,484
| +0.9% | +$3.5M |
|
40
Infosys
INFY
$48.4B
| $410M | 0.85% |
42,938,290
-396,172
| -0.9% | -$3.39M |
|
|
41
ExxonMobil
XOM
$651B
| $407M | 0.85% |
5,473,828
+983,937
| +22% | +$75.8M |
|
42
Oracle
ORCL
$367B
| $405M | 0.84% |
11,220,805
-114,543
| -1% | -$4.4M |
|
43
Cisco
CSCO
$448B
| $403M | 0.84% |
15,351,621
-115,155
| -0.7% | -$3.11M |
|
44
Lloyds Banking Group
LYG
$90.7B
| $392M | 0.82% |
85,225,871
-553,825
| -0.6% | -$2.77M |
|
45
SAP
SAP
$209B
| $391M | 0.81% |
6,030,675
+53,074
| +0.9% | +$3.66M |
|
46
Merck
MRK
$321B
| $334M | 0.7% |
7,086,268
-78,433
| -1% | -$4.17M |
|
47
iShares MBS ETF
MBB
$39.1B
| $323M | 0.67% |
2,944,246
+211,031
| +8% | +$23M |
|
48
Dr. Reddy's Laboratories
RDY
$9.85B
| $317M | 0.66% |
24,807,750
-1,183,520
| -5% | -$14.7M |
|
49
Barclays
BCS
$93.4B
| $290M | 0.6% |
20,989,662
+1,054,437
| +5% | +$16.2M |
|
50
SLB Ltd
SLB
$72.6B
| $289M | 0.6% |
4,190,732
-48,991
| -1% | -$3.88M |
|
Similar funds
Ken Fisher's Q3 2015 Portfolio in Review
As of Q3 2015, Ken Fisher held 777 positions worth $48B, down 6.7% from $51.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher's Q3 2015 filing shows 146 new, 253 increased, 242 reduced and 62 closed positions. Its largest new stake was First American: 571,175 shares worth $22.3M. The largest sale was Toyota, an estimated $571M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.
- Ken Fisher's largest Q3 2015 buy was First American: 571,175 shares worth $22.3M.
- Ken Fisher added most to AB InBev in Q3 2015, an estimated $543M increase.
- Ken Fisher's biggest Q3 2015 reduction was Toyota, cutting an estimated $571M.
- Ken Fisher fully exited STANCORP FINL GRP in Q3 2015, selling an estimated $39.1M.
- Ken Fisher's ten largest holdings make up 23% of its $48B portfolio in Q3 2015.
- Ken Fisher opened 146 new positions and closed 62 in Q3 2015.
- Ken Fisher's portfolio value fell 6.7% quarter-over-quarter to $48B.
Based on Fisher Asset Management's 13F filing for Q3 2015, filed 20 Oct 2015.